These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 4082804)

  • 1. [High recurrence rate following axillofemoral bypass: is continued use still justified?].
    Hepp W; Pallua N
    Zentralbl Chir; 1985; 110(18):1138-46. PubMed ID: 4082804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Present role of extraanatomic bypass graft procedures for aortoiliac occlusive disease.
    Dé P; Hepp W
    Int Angiol; 1991; 10(4):224-8. PubMed ID: 1797932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of extraanatomic bypass in the management of bilateral aortoiliac occlusive disease.
    Schneider JR; Golan JF
    Semin Vasc Surg; 1994 Mar; 7(1):35-44. PubMed ID: 8180754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of aortoiliac disease by axillofemoral artery bypass.
    Sheiner NM
    Can J Surg; 1979 Jan; 22(1):19-21. PubMed ID: 156061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extra-anatomical grafting for aorto-occlusive disease: the outcome in 133 procedures.
    Schroe H; Nevelsteen A; Suy R
    Acta Chir Belg; 1990; 90(5):240-3. PubMed ID: 2073010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal.
    Seeger JM; Pretus HA; Welborn MB; Ozaki CK; Flynn TC; Huber TS
    J Vasc Surg; 2000 Sep; 32(3):451-9; discussion 460-1. PubMed ID: 10957651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillofemoral bypass: outcome and hemodynamic results in high-risk patients.
    Schneider JR; McDaniel MD; Walsh DB; Zwolak RM; Cronenwett JL
    J Vasc Surg; 1992 Jun; 15(6):952-62; discussion 962-3. PubMed ID: 1597893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillofemoral bypass in poor risk patients with critical ischaemia.
    Corbett CR; Taylor PR; Chilvers AS; Edwards JM
    Ann R Coll Surg Engl; 1984 May; 66(3):170-2. PubMed ID: 6721403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term results after recanalization of acute and subacute thrombotic occlusions of the infra-aortic arteries and bypass-grafts using a rotational thrombectomy device].
    Zeller T; Frank U; Bürgelin K; Schwarzwälder U; Horn B; Flügel PC; Neumann FJ
    Rofo; 2002 Dec; 174(12):1559-65. PubMed ID: 12471529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillofemoral bypass: a tool with a limited role.
    Donaldson MC; Louras JC; Bucknam CA
    J Vasc Surg; 1986 May; 3(5):757-63. PubMed ID: 2939265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillounifemoral and axillobifemoral bypasses. Retrospective study of 85 cases.
    Dujardin P; Lavigne JP; Defraigne JO; Horion C; Creemers E; Limet R
    Acta Chir Belg; 1991; 91(4):155-60. PubMed ID: 1950296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dacron and polytetrafluoroethylene aorto-bifemoral grafts].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanović PL; Velimirović LB; Marković DM; Pejkić SL; Pavlović G
    Srp Arh Celok Lek; 1997; 125(3-4):75-83. PubMed ID: 9221522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Axillo-femoral bypass: indications and results].
    Eggli S; von Flüe M; Vogt B
    Helv Chir Acta; 1992 Aug; 59(2):307-9. PubMed ID: 1428918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of externally supported Dacron and polytetrafluoroethylene prosthetic bypasses for femorofemoral and axillofemoral arterial reconstructions. Veterans Affairs Cooperative Study #141.
    Johnson WC; Lee KK
    J Vasc Surg; 1999 Dec; 30(6):1077-83. PubMed ID: 10587392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved patency after axillofemoral bypass for aortoiliac occlusive disease.
    Samson RH; Showalter DP; Lepore MR; Nair DG; Dorsay DA; Morales RE
    J Vasc Surg; 2018 Nov; 68(5):1430-1437. PubMed ID: 29691098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The iliac-origin arterial graft: a useful alternative for iliac occlusive disease.
    Couch NP; Clowes AW; Whittemore AD; Lombara JA; Henderson BA; Mannick JA
    Surgery; 1985 Jan; 97(1):83-7. PubMed ID: 3966232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superficial femoral vein and superficial femoral artery as replacement for infected axillofemoral graft.
    Wojciechowski J; Znaniecki L; Zelechowski P
    Ann Vasc Surg; 2006 Jul; 20(4):544-6. PubMed ID: 16625414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillofemoral bypass for aortoiliac occlusive disease.
    Martin D; Katz SG
    Am J Surg; 2000 Aug; 180(2):100-3. PubMed ID: 11044521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of axillounifemoral and axillobifemoral bypass operations.
    Ascer E; Veith FJ; Gupta SK; Scher LA; Samson RH; White-Flores SA; Sprayregen S
    Surgery; 1985 Feb; 97(2):169-75. PubMed ID: 3969621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.